Cargando…
Economic evaluation for mass vaccination against COVID-19
BACKGROUND: Vaccine is supposed to be the most effective means to prevent COVID-19 as it may not only save lives but also reduce productivity loss due to resuming pre-pandemic activities. Providing the results of economic evaluation for mass vaccination is of paramount importance for all stakeholder...
Autores principales: | Wang, Wei-Chun, Fann, Jean Ching-Yuan, Chang, Ray-E, Jeng, Ya-Chung, Hsu, Chen-Yang, Chen, Hsiu-Hsi, Liu, Jin-Tan, Yen, Amy Ming-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Formosan Medical Association. Published by Elsevier Taiwan LLC.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148613/ https://www.ncbi.nlm.nih.gov/pubmed/34108119 http://dx.doi.org/10.1016/j.jfma.2021.05.020 |
Ejemplares similares
-
Personalized risk assessment for dynamic transition of gastric neoplasms
por: Fann, Jean Ching-Yuan, et al.
Publicado: (2018) -
Heterogeneity in Cost-Effectiveness Analysis of Vaccination for Mild and Moderate Alzheimer’s Disease
por: Lin, Chung-Hsien, et al.
Publicado: (2019) -
Evaluation of Abdominal Ultrasonography Mass Screening for Hepatocellular Carcinoma in Taiwan
por: Yeh, Yen-Po, et al.
Publicado: (2014) -
Increased Risk of Hemorrhagic Stroke in Patients with Migraine: A Population-Based Cohort Study
por: Kuo, Cheng-Ya, et al.
Publicado: (2013) -
Parkinson’s Disease Is Related to an Increased Risk of Ischemic Stroke—A Population-Based Propensity Score-Matched Follow-Up Study
por: Huang, Ya-Ping, et al.
Publicado: (2013)